| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |